0001209191-23-054549.txt : 20231106
0001209191-23-054549.hdr.sgml : 20231106
20231106170741
ACCESSION NUMBER: 0001209191-23-054549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231102
FILED AS OF DATE: 20231106
DATE AS OF CHANGE: 20231106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amoroso Michael
CENTRAL INDEX KEY: 0001830874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 231380712
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-02
0
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001830874
Amoroso Michael
C/O PRECISION BIOSCIENCES, INC.
302 E. PETTIGREW STREET, SUITE A-100
DURHAM
NC
27701
1
1
0
0
President and CEO
1
Common Stock
2023-11-02
4
M
0
283390
A
352128
D
Common Stock
2023-11-03
4
S
0
125025
0.40
D
227103
D
Restricted Stock Units
2023-11-02
4
M
0
283390
0.00
D
Common Stock
283390
566610
D
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.
The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
/s/ Dario Scimeca, Attorney-in-Fact for Michael Amoroso
2023-11-06